{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:31:11Z","timestamp":1793316671276,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00415-019-09374-1","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T20:22:02Z","timestamp":1558556522000},"page":"2027-2034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of autoimmune comorbidity on fatigue, sleepiness and mood in myasthenia gravis"],"prefix":"10.1007","volume":"266","author":[{"given":"T. M.","family":"Alekseeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. A.","family":"Kreis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. V.","family":"Gavrilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8435-1697","authenticated-orcid":false,"given":"P. O.","family":"Valko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. P.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6147-1960","authenticated-orcid":false,"given":"Yulia","family":"Valko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"key":"9374_CR1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE (2016) Myasthenia gravis. N Engl J Med 375:2570\u20132581","journal-title":"N Engl J Med"},{"key":"9374_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/aje\/kwn408","volume":"169","author":"EC Somers","year":"2009","unstructured":"Somers EC, Thomas SL, Smeeth L, Hall AJ (2009) Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? Am J Epidemiol 169:749\u2013755","journal-title":"Am J Epidemiol"},{"key":"9374_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/003693306000501001","volume":"5","author":"JA Simpson","year":"1960","unstructured":"Simpson JA (1960) Myasthenia gravis: a new hypothesis. Scott Med J 5:419\u2013436","journal-title":"Scott Med J"},{"key":"9374_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ene.12599","volume":"22","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Nacu A, Andersen JB, Owe JF (2015) Myasthenia gravis and risks for comorbidity. Eur J Neurol 22:17\u201323","journal-title":"Eur J Neurol"},{"key":"9374_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/00207454.2010.539307","volume":"121","author":"ZF Mao","year":"2011","unstructured":"Mao ZF, Yang LX, Mo XA et al (2011) Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int J Neurosci 121:121\u2013129","journal-title":"Int J Neurosci"},{"key":"9374_CR6","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","volume":"330","author":"DB Drachman","year":"1994","unstructured":"Drachman DB (1994) Myasthenia gravis. N Engl J Med 330:1797\u20131810","journal-title":"N Engl J Med"},{"key":"9374_CR7","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/ene.12169","volume":"20","author":"R Nakata","year":"2013","unstructured":"Nakata R, Motomura M, Masuda T et al (2013) Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis. Eur J Neurol 20:1272\u20131276","journal-title":"Eur J Neurol"},{"key":"9374_CR8","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/joim.12310","volume":"277","author":"F Fang","year":"2014","unstructured":"Fang F, Sveinsson O, Thormar G et al (2014) The autoimmune spectrum of myasthenia gravis: a Swedish population-based study. J Intern Med 277:594\u2013604","journal-title":"J Intern Med"},{"key":"9374_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1034\/j.1600-0404.2002.01191.x","volume":"106","author":"D Ratanakorn","year":"2002","unstructured":"Ratanakorn D, Vejjajiva A (2002) Long-term follow-up of myasthenia gravis patients with hyperthyroidism. Acta Neurol Scand 106:93\u201398","journal-title":"Acta Neurol Scand"},{"key":"9374_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1600-0404.2006.00649.x","volume":"114","author":"C Toth","year":"2006","unstructured":"Toth C, McDonald D, Oger J, Brownell K (2006) Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease. Acta Neurol Scand 114:124\u2013132","journal-title":"Acta Neurol Scand"},{"key":"9374_CR11","first-page":"438","volume":"82","author":"M Marin\u00f3","year":"1997","unstructured":"Marin\u00f3 M, Ricciardi R, Pinchera A et al (1997) Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab 82:438\u2013443","journal-title":"J Clin Endocrinol Metab"},{"key":"9374_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1600-0404.2012.01693.x","volume":"127","author":"YL Chen","year":"2013","unstructured":"Chen YL, Yeh JH, Chiu HC (2013) Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan. Acta Neurol Scand 127:170\u2013174","journal-title":"Acta Neurol Scand"},{"key":"9374_CR13","doi-asserted-by":"publisher","first-page":"e00537","DOI":"10.1002\/brb3.537","volume":"6","author":"J Kubiszewska","year":"2016","unstructured":"Kubiszewska J, Szyluk B, Szczudlik P et al (2016) Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course. Brain Behav 6:e00537","journal-title":"Brain Behav"},{"key":"9374_CR14","first-page":"54","volume":"18","author":"JF T\u00e9llez-Zenteno","year":"2003","unstructured":"T\u00e9llez-Zenteno JF, Remes-Troche JM, Mimenza-Alvarado A, Garcia-Ramos G, Estanol B, Vega-Boada F (2003) The association of myasthenia gravis and connective tissue diseases. Effects of thymectomy in six cases with rheumatoid arthritis and one case with systemic lupus erythematosus. Neurologia 18:54\u201358","journal-title":"Neurologia"},{"key":"9374_CR15","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1007\/s00415-011-6335-z","volume":"259","author":"M Jallouli","year":"2012","unstructured":"Jallouli M, Saadoun D, Eymard B et al (2012) The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature. J Neurol 259:1290\u20131297","journal-title":"J Neurol"},{"key":"9374_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/ane.12374","volume":"132","author":"JH Yeh","year":"2015","unstructured":"Yeh JH, Chen HJ, Lin CC, Chen YK, Chiu HC, Kao CH (2015) Risk of diabetes mellitus among patients with myasthenia gravis. Acta Neurol Scand 132:132\u2013138","journal-title":"Acta Neurol Scand"},{"key":"9374_CR17","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/j.1468-1331.2007.01978.x","volume":"14","author":"M Kanazawa","year":"2007","unstructured":"Kanazawa M, Shimohata T, Tanaka K, Nishizawa M (2007) Clinical features of patients with myasthenia gravis associated with autoimmune diseases. Eur J Neurol 14:1403\u20131404","journal-title":"Eur J Neurol"},{"key":"9374_CR18","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s00415-018-8995-4","volume":"265","author":"TM Alekseeva","year":"2018","unstructured":"Alekseeva TM, Gavrilov YV, Kreis OA et al (2018) Fatigue in patients with myasthenia gravis. J Neurol 265:2312\u20132321","journal-title":"J Neurol"},{"key":"9374_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tins.2013.10.003","volume":"37","author":"R Dantzer","year":"2014","unstructured":"Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L (2014) The neuroimmune basis of fatigue. Trends Neurosci 37:39\u201346","journal-title":"Trends Neurosci"},{"key":"9374_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46\u201356","journal-title":"Nat Rev Neurosci"},{"key":"9374_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrn2576","volume":"10","author":"L Imeri","year":"2009","unstructured":"Imeri L, Opp MR (2009) How (and why) the immune system makes us sleep. Nat Rev Neurosci 10:199\u2013210","journal-title":"Nat Rev Neurosci"},{"key":"9374_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/7854_2016_7","volume":"31","author":"CR Pryce","year":"2017","unstructured":"Pryce CR, Fontana A (2017) Depression in autoimmune diseases. Curr Top Behav Neurosci 31:139\u2013154","journal-title":"Curr Top Behav Neurosci"},{"key":"9374_CR23","doi-asserted-by":"publisher","first-page":"e835","DOI":"10.1097\/MD.0000000000000835","volume":"94","author":"JH Yeh","year":"2015","unstructured":"Yeh JH, Kuo HT, Chen HJ, Chen YK, Chiu HC, Kao CH (2015) Higher risk of myasthenia gravis in patients with thyroid and allergic diseases: a national population-based study. Medicine (Baltimore) 94:e835","journal-title":"Medicine (Baltimore)"},{"key":"9374_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1586\/eci.12.34","volume":"8","author":"MN Meriggioli","year":"2012","unstructured":"Meriggioli MN, Sanders DB (2012) Muscle autoantibodies in myasthenia gravis: beyond diagnosis? Expert Rev Clin Immunol 8:427\u2013438","journal-title":"Expert Rev Clin Immunol"},{"key":"9374_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki","year":"2000","unstructured":"Jaretzki A, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323","journal-title":"Neurology"},{"key":"9374_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/ane.12993","volume":"138","author":"YV Gavrilov","year":"2018","unstructured":"Gavrilov YV, Shkilnyuk GG, Valko PO et al (2018) Validation of the Russian version of the Fatigue Impact Scale and Fatigue Severity Scale in multiple sclerosis patients. Acta Neurol Scand 138:408\u2013416","journal-title":"Acta Neurol Scand"},{"key":"9374_CR27","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121\u20131123","journal-title":"Arch Neurol"},{"key":"9374_CR28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540\u2013545","journal-title":"Sleep"},{"key":"9374_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561\u2013571","journal-title":"Arch Gen Psychiatry"},{"key":"9374_CR30","volume-title":"State-trait anxiety inventory","author":"CD Spielberger","year":"1983","unstructured":"Spielberger CD (1983) State-trait anxiety inventory. Consulting Psychologists Press, Palo Alto"},{"key":"9374_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1212\/01.wnl.0000223515.15691.26","volume":"67","author":"MW Nicolle","year":"2006","unstructured":"Nicolle MW, Rask S, Koopman WJ, George CF, Adams J, Wiebe S (2006) Sleep apnea in patients with myasthenia gravis. Neurology 67:140\u2013142","journal-title":"Neurology"},{"key":"9374_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamapsychiatry.2018.0190","volume":"75","author":"EM Siegmann","year":"2018","unstructured":"Siegmann EM, M\u00fcller HHO, Luecke C, Philipsen A, Kornhuber J, Gr\u00f6mer TW (2018) Association of depression and anxiety disorders with autoimmune thyroiditis: a systematic review and meta-analysis. JAMA Psychiatry 75:577\u2013584","journal-title":"JAMA Psychiatry"},{"key":"9374_CR33","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","volume":"390","author":"L Chaker","year":"2017","unstructured":"Chaker L, Bianco AC, Jonklaas J, Peeters RP (2017) Hypothyroidism. Lancet 390:1550\u20131562","journal-title":"Lancet"},{"key":"9374_CR34","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","volume":"388","author":"S De Leo","year":"2016","unstructured":"De Leo S, Lee SY, Braverman LE (2016) Hyperthyroidism. Lancet 388:906\u2013918","journal-title":"Lancet"},{"key":"9374_CR35","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3109\/08916934.2015.1030614","volume":"48","author":"A Nacu","year":"2015","unstructured":"Nacu A, Andersen JB, Lisnic V, Owe JF, Gilhus NE (2015) Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity 48:362\u2013368","journal-title":"Autoimmunity"},{"key":"9374_CR36","first-page":"24","volume":"15","author":"VA Kuz\u2019mina","year":"2011","unstructured":"Kuz\u2019mina VA, Serebryakova IP, Volkova EA, Kuznetzova AV, Kryuchkova ZV (2011) Structure of the thyroid gland diseases in young adults, residents of St. Petersburg [in Russian]. Rossiskij Semejnij Vrach 15:24\u201328","journal-title":"Rossiskij Semejnij Vrach"},{"key":"9374_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","volume":"42","author":"DS McLeod","year":"2012","unstructured":"McLeod DS, Cooper DS (2012) The incidence and prevalence of thyroid autoimmunity. Endocrine 42:252\u2013265","journal-title":"Endocrine"},{"key":"9374_CR38","unstructured":"Dora SV, Krasilnikova EI, Volkova AR, Kravtzova VD, Gudiyeva MB, Grigoryeva EA (2012) Correlation between iodine supplementation indices and frequency of autoimmune thyroiditis [in Russian]. Sci Notes IP Pavlov St Petersburg State Med Univ 19:108\u2013110"},{"key":"9374_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1089\/thy.2014.0182","volume":"25","author":"DM Miranda","year":"2015","unstructured":"Miranda DM, Massom JN, Catarino RM et al (2015) Impact of nutritional iodine optimization on rates of thyroid hypoechogenicity and autoimmune thyroiditis: a cross-sectional, comparative study. Thyroid 25:118\u2013124","journal-title":"Thyroid"},{"key":"9374_CR40","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0140-6736(97)11397-6","volume":"352","author":"F Pacini","year":"1998","unstructured":"Pacini F, Vorontsova T, Molinaro E et al (1998) Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout. Lancet 352:763\u2013766","journal-title":"Lancet"},{"key":"9374_CR41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jpeds.2017.11.026","volume":"196","author":"N Marcus","year":"2018","unstructured":"Marcus N, Amir AZ, Grunebaum E et al (2018) De novo allergy and immune-mediated disorders following solid-organ transplantation-prevalence, natural history, and risk factors. J Pediatr 196:154\u2013160","journal-title":"J Pediatr"},{"key":"9374_CR42","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1182\/blood-2011-02-336156","volume":"118","author":"T Daikeler","year":"2011","unstructured":"Daikeler T, Labopin M, Di Gioia M et al (2011) Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party. Blood 118:1693\u20131698","journal-title":"Blood"},{"key":"9374_CR43","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1210\/jc.2011-1600","volume":"96","author":"AL Skversky","year":"2011","unstructured":"Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, Melamed ML (2011) Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001\u20132006. J Clin Endocrinol Metab 96:3838\u20133845","journal-title":"J Clin Endocrinol Metab"},{"key":"9374_CR44","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0002-9343(02)01022-7","volume":"112","author":"WM Kong","year":"2002","unstructured":"Kong WM, Sheikh MH, Lumb PJ et al (2002) A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med 112:348\u2013354","journal-title":"Am J Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09374-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09374-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09374-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T23:27:26Z","timestamp":1589930846000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09374-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["9374"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09374-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]},"assertion":[{"value":"20 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors declare that the work documented in this\nmanuscript has been carried out in accordance with ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard"}}]}}